Emergent BioSolutions Inc.

EBS | NYSE

Price Alert Chart Builder DCF Calculator

$6.55

-$0.25 (-3.68%)

At close: Sep 21, 2026, 4:00 PM ET

$6.55

$0 (0.00%)

After-hours: Sep 21, 2026, 4:18 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.68%

(1D)

Rating

Updated: Sep 1, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $337.96M

1D Range

6.52 6.87

52W Range

4.36 14.06

Valuation (TTM)

PE -1.85

PB 0.99

EV/EBITDA -32.91

Valuation (NTM)

Forward PE 6.54

Forward PEG -0.01

Price Target $10

Cash Flow

FCF Yield 4.0%

SBC Adj. FCF Yield -1.6%

SBC Impact -139.0%

Margins

Gross Margin 49.4%

Operating Margin -7.1%

FCF Margin 1.8%

Growth (CAGR)

Revenue 3Y | 5Y -10.4% | -14.7%

Dil EPS 3Y | 5Y 93.6% | 8.9%

FCF 3Y | 5Y -17.5% | -35.4%

Returns

ROA -15.8%

ROE -35.9%

ROIC -5.5%

Financial Health

Net Debt

$442.1M

Current Ratio 5.42

Interest Coverage -1.07

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These ...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 900

IPO Date Nov 14, 2006

Website www.emergentbiosolutions.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$10

Upside

+52.67%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞